---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-029115"
form_type: "8-K"
ticker: null
cik: "0001289850"
company_name: "NeuroMetrix, Inc."
filed_at: "2023-08-11T23:59:59+00:00"
generated_at: "2026-06-11T13:57:18.527375+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nasdaq warns NeuroMetrix (NURO) of delisting for bid price below $1.00; 180-day cure period

## Summary
- Received Nasdaq notice on Aug 8, 2023 for failure to meet minimum $1.00 bid price per share for 30 consecutive business days.
- Has 180 calendar days, until Feb 5, 2024, to regain compliance by closing at $1.00 or more for ten consecutive business days.
- If not compliant by deadline, Nasdaq may delist; company can appeal or seek an additional 180-day grace period if eligible.
- Stock remains listed on The Nasdaq Capital Market; the notice has no immediate effect on trading.
- Company intends to actively monitor its bid price to regain compliance.

## SEC filing metadata
- accession: 0001628280-23-029115
- form_type: 8-K
- cik: 0001289850
- company_name: NeuroMetrix, Inc.
- filed_at: 2023-08-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289850/000162828023029115/0001628280-23-029115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289850/000162828023029115/nuro-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-029115
- JSON: https://secwatch.observer/filing/0001628280-23-029115.json
- Plain text: https://secwatch.observer/filing/0001628280-23-029115.txt

## Key facts
- Listing & Compliance Notices
  NeuroMetrix, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: August 8, 2023, NeuroMetrix, Inc. (the “Company”) received a notice from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The notice states that pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company will be afforded 180 calendar days, or until February 5, 2024, to regain compliance with the minimum bid price require
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289850/000162828023029115/0001628280-23-029115-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
